[Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pa
about
[Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pa
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
[Chances and risks of blood-ba ...... working group for molecular pa
@en
[Chances and risks of blood-ba ...... sis of circulating tumor cells
@nl
type
label
[Chances and risks of blood-ba ...... working group for molecular pa
@en
[Chances and risks of blood-ba ...... sis of circulating tumor cells
@nl
prefLabel
[Chances and risks of blood-ba ...... working group for molecular pa
@en
[Chances and risks of blood-ba ...... sis of circulating tumor cells
@nl
P2093
P2860
P1433
P1476
[Chances and risks of blood-ba ...... working group for molecular pa
@en
P2093
P2860
P2888
P356
10.1007/S00292-014-2069-X
P577
2015-02-01T00:00:00Z